Logo image
Data on the power of high betatrophin to predict cardiovascular deaths in coronary patients
Journal article   Open access   Peer reviewed

Data on the power of high betatrophin to predict cardiovascular deaths in coronary patients

Andreas Leiherer, Janine Ebner, Axel Muendlein, Eva M. Brandtner, Christina Zach, Kathrin Geiger, Peter Fraunberger and Heinz Drexel
Data in brief, v 28, 104989
01 Feb 2020
PMID: 31890821
url
https://doi.org/10.1016/j.dib.2019.104989View
Published, Version of Record (VoR) Open CC BY V4.0

Abstract

ANGPTL8 Betatrophin Biomarker Cardiovascular death Cardiovascular events Coronary patients Lipasin
Betatrophin is a protein which is produced by the liver and by adipose tissue. There are no clear data about serum betatrophin's cardiovascular role and it is unknown, whether betatrophin is associated with the risk of cardiovascular death. This article provides additional data on the association of betatrophin with its power to predict cardiovascular death in coronary patients. In addition, this data article demonstrates the performance of betatrophin as a biomarker using c-statistics. Analyzed data was derived from 553 coronary patients. Betatrophin was measured in serum samples and cardiovascular deaths were recorded for a median of 7.1 years. This data article is related to a research article titled “High betatrophin in coronary patients protects from cardiovascular events” [1].

Metrics

6 Record Views
2 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Multidisciplinary Sciences
Logo image